Most investors still describe Rocket Lab as a small-rocket company.
That description is already outdated.
The real Rocket Lab thesis is not that Electron will launch more small satellites. It is that Rocket Lab could eventually design the satellite, manufacture its components, launch it, operate the constellation, and collect recurring revenue from the services it provides.
That is a much larger opportunity.
It is also a much more difficult company to build.
At RKLB's September 23 closing price of $70.31, the market is no longer pricing Rocket Lab as an interesting space startup. It is pricing the company as a future space infrastructure giant. RKLB price history
The question is no longer whether Rocket Lab has potential.
Of course it does.
The question is how much of that potential has already been priced into the stock.
Rocket Lab is not one business
A useful way to understand Rocket Lab is to separate it into four layers.
Electron provides launch access.
Space Systems provides the hardware that goes into orbit.
Neutron is supposed to bring scale.
Iridium would add recurring revenue from operating infrastructure in space.
That progression matters because launch alone is a difficult business.
Rockets are expensive to develop. Launch schedules are irregular. A single failure can interrupt revenue, increase costs, and delay customer missions.
But what if the same company could sell the rocket, the satellite, the components inside the satellite, the ground systems that control it, and the communications service it provides after reaching orbit?
Now we are talking about something much more powerful.
We are talking about a vertically integrated space platform.
Electron proved that Rocket Lab can execute
Electron is no longer an experimental rocket.
Rocket Lab completed Electron's 96th mission in September, marking its 17th launch of 2026. That operating history gives Rocket Lab something most aspiring space companies do not have:
Credibility.
Customers know that Electron works. Government agencies know Rocket Lab can execute responsive missions. Engineers have accumulated real production, launch, and mission-control experience. Rocket Lab's 96th Electron mission
Why does that matter?
Because Rocket Lab is not trying to build Neutron from a PowerPoint presentation.
It is building Neutron on top of an existing launch organization with factories, launch sites, customer relationships, regulatory experience, and a demonstrated ability to reach orbit.
That does not guarantee Neutron will succeed.
But it substantially improves the starting position.
Electron also serves missions that larger rockets cannot always serve efficiently. Some customers want a dedicated launch, a specific orbit, or a rapid-response capability. They do not want to wait for a rideshare slot on a larger vehicle.
Electron gives Rocket Lab a defensible role even in a market dominated by SpaceX.
The goal is not to beat Falcon 9 at everything.
The goal is to be extremely good at the missions where dedicated small launch matters.
The rocket is no longer the largest business
Here is the fact that changes how investors should think about Rocket Lab:
In the second quarter of 2026, Rocket Lab generated $234.1 million in revenue.
Only $44.6 million came from launch services.
The remaining $189.5 million, or approximately 81% of total revenue, came from Space Systems. Rocket Lab Q2 2026 Form 10-Q
Space Systems includes satellite manufacturing, solar products, reaction wheels, star trackers, separation systems, radios, batteries, optical communications, space robotics, mission software, and other spacecraft components.
This is important because every satellite launched into orbit needs far more than a rocket.
It needs power.
It needs communications.
It needs navigation.
It needs thermal management.
It needs software.
It needs components capable of surviving radiation, vibration, and extreme temperature changes.
Rocket Lab increasingly sells those products regardless of whose rocket launches the satellite.
That makes Space Systems the current revenue engine while Electron remains the company's most visible product.
The rocket attracts attention.
The satellite hardware produces most of the revenue.
The financial momentum is real
Rocket Lab's second-quarter revenue increased 62% year-over-year to a record $234 million.
Backlog reached $2.36 billion, an increase of 137% year-over-year.
Management guided for third-quarter revenue between $250 million and $265 million, which would represent another quarterly record. Rocket Lab Q2 2026 results
The backlog is also reasonably balanced:
- Approximately $1.42 billion comes from Space Systems.
- Approximately $940 million comes from launch services.
- Approximately 45% was expected to convert into revenue within twelve months.
Why does that matter?
Because Rocket Lab is not entirely dependent on a single product or customer category.
However, backlog is not the same as cash flow.
Government contracts can include options that may never be exercised. Fixed-price programs can become less profitable when development costs increase. Launch schedules can move. Satellite deliveries can be delayed by suppliers or technical problems.
The backlog demonstrates demand.
It does not eliminate execution risk.
That distinction matters.
Neutron is the largest upside catalyst
Electron can carry relatively small payloads.
Neutron is designed to carry up to 13,000 kilograms to low Earth orbit, placing Rocket Lab in an entirely different market.
This would allow the company to compete for larger commercial constellations, national-security missions, cargo missions, and potentially human-spaceflight support.
More importantly, Neutron could allow Rocket Lab to launch the satellite constellations that its own Space Systems division builds.
That is where vertical integration becomes interesting.
A customer could hire Rocket Lab to design a constellation, manufacture the satellites, launch them on Neutron, and operate the system after deployment.
One company.
One contract.
One accountable supplier.
That proposition should be attractive to government customers looking for credible alternatives to SpaceX and traditional defense contractors.
But Neutron remains the largest uncertainty in the thesis.
Following a Stage 1 tank test failure, Rocket Lab moved the inaugural launch target to the fourth quarter of 2026. The company subsequently said production of the new Stage 1 tank remained aligned with delivery to the launch pad during that quarter, while acknowledging that the exact year-end launch window was narrowing. Rocket Lab Neutron test update Q2 2026 progress update
Investors should not confuse delivery to the launch pad with a successful commercial launch.
The first flight matters.
But the second, third, and fourth flights matter even more.
A rocket does not become an economically useful platform because it launches successfully once. It becomes useful when it can launch repeatedly, reliably, and at an acceptable cost.
That is what Rocket Lab still needs to prove.
Iridium changes the entire business model
Rocket Lab's proposed acquisition of Iridium is one of the boldest strategic moves in the space industry.
Under the agreement, Rocket Lab would acquire Iridium for approximately $8 billion in enterprise value, paying Iridium shareholders $27 in cash and $27 in Rocket Lab stock, subject to an exchange-ratio collar. The acquisition is expected to close in mid-2027, subject to regulatory approvals. Iridium acquisition announcement
Why buy Iridium?
Because Iridium provides what Rocket Lab currently lacks:
A profitable, operating satellite network with recurring service revenue.
Iridium generated $225.2 million in second-quarter revenue. Approximately 72% came from service revenue, which primarily represents recurring revenue from subscribers. The company also produced $119.1 million in operational EBITDA during the quarter. Iridium Q2 2026 results
Compare the two companies.
Rocket Lab has rapid growth, engineering talent, launch capability, satellite manufacturing, and ambitious new programs.
Iridium has an operating constellation, valuable spectrum, millions of connected devices, recurring subscriptions, and substantial cash generation.
Rocket Lab builds and launches infrastructure.
Iridium monetizes infrastructure already operating in space.
Put them together and Rocket Lab would be able to design, build, launch, operate, and monetize a satellite network.
That is the bull case in one sentence.
Electron proved Rocket Lab can reach orbit. Space Systems proved it can build what goes there. Neutron is meant to scale the economics. Iridium would let Rocket Lab own what happens after launch.
The acquisition also introduces a new kind of risk
The strategic logic is compelling.
The execution challenge is enormous.
Rocket Lab is attempting to build a reusable medium-lift rocket while integrating multiple acquisitions and preparing to absorb a communications company nearly as large as Rocket Lab's own current revenue base.
This is no longer a simple launch-company story.
Rocket Lab would be managing rocket development, satellite manufacturing, defense programs, optical communications, constellation operations, spectrum assets, subscribers, and a larger debt structure.
Can management execute across all of those businesses simultaneously?
Maybe.
But investors should not dismiss the organizational complexity simply because the strategic presentation looks attractive.
Vertical integration creates value when the pieces reinforce one another.
It destroys value when management collects businesses faster than it can integrate them.
The balance sheet looks strong, but shareholders paid for it
At the end of June, Rocket Lab held approximately $2.39 billion in cash and marketable securities.
That gives the company substantial resources to fund Neutron, working capital, acquisitions, and infrastructure. Rocket Lab Q2 2026 Form 10-Q
But that cash did not appear by magic.
During the first half of 2026, Rocket Lab raised approximately $1.53 billion through equity offerings.
It subsequently raised another $1.944 billion by issuing 29.3 million shares, primarily to fund the cash portion of the Iridium acquisition. Rocket Lab also arranged for Iridium's existing $1.775 billion term loan to remain in place following the transaction. Iridium acquisition financing
Selling stock at an elevated valuation can be excellent capital allocation.
If management converts that capital into assets worth more than the ownership percentage shareholders surrendered, the dilution creates value.
But dilution still matters.
The business can grow rapidly while value per share grows much more slowly.
That is why Rocket Lab's economic share count matters just as much as revenue.
The correct question is not:
“Is Rocket Lab getting bigger?”
It clearly is.
The correct question is:
“Is Rocket Lab creating value faster than it is issuing shares?”
That answer remains unproven.
Rocket Lab is still consuming cash
Rocket Lab used $134.4 million of cash in operating activities during the first half of 2026 and spent another $53.1 million on property, equipment, and software.
Some of this spending represents working-capital investment and inventory needed to support future growth.
Some of it represents the unavoidable cost of developing Neutron and expanding manufacturing capacity.
That does not make the spending bad.
But it does mean investors should not value Rocket Lab as though its current revenue immediately translates into distributable cash flow.
The company is building ahead of demand.
That creates operating leverage if the demand arrives.
It creates overcapacity if it does not.
What does the current price already assume?
Using Rocket Lab's common and economically equivalent preferred shares, plus the recently issued ATM shares, I estimate that the company has approximately 668 million economic shares before issuing the additional stock consideration for Iridium.
At $70.31 per share, that represents an equity value of roughly $47 billion before accounting for the additional acquisition shares.
Once the Iridium stock consideration and retained debt are included, the market is effectively valuing the future combined enterprise at approximately $50 billion. This is my analytical estimate, not a company-provided figure.
Rocket Lab and Iridium generated approximately $459 million in combined second-quarter revenue.
Annualized, that is approximately $1.84 billion.
I would not treat one quarter multiplied by four as a forecast. But it gives us a useful scale comparison.
A roughly $50 billion enterprise value against a $1.8 billion combined revenue run rate means investors are paying approximately 27 times current annualized revenue for the future combined company.
That is not a normal industrial valuation.
It is a venture-style valuation being applied in the public market.
To support a $50 billion enterprise value at a future multiple of 20 times EBITDA, the combined company would eventually need approximately $2.5 billion in annual EBITDA.
At a 30% EBITDA margin, that would require more than $8 billion in annual revenue.
At a 25% margin, it would require approximately $10 billion.
The current price therefore assumes much more than a successful Electron business.
It assumes Neutron works.
It assumes Neutron reaches commercial cadence.
It assumes defense contracts convert into profitable revenue.
It assumes Space Systems continues scaling.
It assumes Iridium closes and integrates successfully.
It assumes margins expand dramatically.
And it assumes future dilution remains controlled.
That is a lot of success in one share price.
Three possible outcomes
These are analytical 2030 scenarios, not price targets. Their purpose is to show what the current valuation requires.
The conservative outcome
Neutron experiences further delays and takes longer to reach commercial cadence. Space Systems continues growing, but fixed-price programs and manufacturing costs limit margin expansion. Iridium remains stable but does not materially accelerate.
Assumptions:
- 2030 revenue: approximately $4 billion
- EBITDA margin: 20%
- EBITDA: approximately $800 million
- Valuation: 15 times EBITDA
- Net debt: approximately $1 billion
- Diluted shares: approximately 760 million
This produces an estimated value of roughly $14 to $15 per share.
That sounds severe.
But expensive growth stocks do not require the business to fail for the stock to decline. They only require the business to deliver less than the market already expects.
The base outcome
Neutron reaches orbit and becomes commercially viable, although the ramp takes time. Rocket Lab wins additional defense and constellation programs. Space Systems continues expanding. Iridium provides recurring cash flow and helps fund the broader platform.
Assumptions:
- 2030 revenue: approximately $7.5 billion
- EBITDA margin: 27%
- EBITDA: approximately $2 billion
- Valuation: 20 times EBITDA
- Net debt: approximately $500 million
- Diluted shares: approximately 740 million
This produces an estimated value of roughly $52 to $56 per share.
That would represent an excellent operating outcome.
It would also be below the current share price.
This is the danger of paying an extraordinary price for an extraordinary company.
The aggressive outcome
Neutron becomes a credible and frequently launched medium-lift vehicle. Rocket Lab captures major national-security programs, wins commercial constellation business, and successfully uses its vertical integration to reduce cost and accelerate deployments.
Iridium grows recurring services while Rocket Lab uses the combined platform to build and operate additional constellations.
Assumptions:
- 2030 revenue: approximately $10 billion
- EBITDA margin: 32%
- EBITDA: approximately $3.2 billion
- Valuation: 24 times EBITDA
- Limited net debt
- Diluted shares: approximately 730 million
This produces an estimated value of roughly $100 to $108 per share.
That sounds attractive until we consider the time involved.
Turning $70 into approximately $105 by the end of 2030 would produce an annual return of roughly 10%.
In other words, Rocket Lab may need to deliver something close to the aggressive scenario merely to provide an acceptable return from today's price.
That is the valuation problem.
The strongest bull argument
The strongest bull argument is not that space is exciting.
It is that Rocket Lab is building capabilities that are unusually difficult to replicate.
The company has:
- A proven orbital launch vehicle
- Active launch infrastructure
- Medium-lift ambitions through Neutron
- Satellite manufacturing
- Solar and power products
- Guidance, navigation, and control components
- Optical communications
- Space robotics
- Defense relationships
- Mission software and operations
- A pending path into recurring satellite services through Iridium
Few publicly traded companies offer exposure to so many layers of the space economy.
If those pieces work together, Rocket Lab could become one of the most strategically important aerospace companies outside the traditional defense primes.
Government customers also want alternatives.
They do not want one launch provider, one satellite manufacturer, or one communications network to become an unavoidable single point of failure.
Rocket Lab does not need to replace SpaceX.
It needs to become the most credible alternative across several valuable mission categories.
That opportunity is real.
The strongest bear argument
The strongest bear argument is also straightforward:
Rocket Lab is trying to do too much at the same time, and the stock is priced as though nearly everything works.
Neutron could cost more and take longer than expected.
Large fixed-price contracts could generate revenue without producing adequate profits.
Iridium could distract management.
Integration costs could rise.
Debt could become more burdensome.
Additional share issuance could reduce per-share upside.
Competition from SpaceX, Blue Origin, traditional defense contractors, and other satellite manufacturers will not stand still.
Most importantly, even strong execution may not be enough if investors have already paid for exceptional execution.
A great company can still be a poor investment when purchased at the wrong price.
What to watch out for
Watch whether Neutron reaches the launch pad on schedule.
Watch whether Neutron completes a successful first flight.
Watch the second and third flights even more closely, because repeatability matters more than a single demonstration.
Watch Electron's launch cadence, revenue per launch, and cost per launch.
Watch how much of Space Systems growth is organic rather than acquired.
Watch whether Space Systems gross margins improve as manufacturing scales.
Watch backlog conversion, especially the difference between firm orders, contract options, and large program ceilings.
Watch whether fixed-price government contracts generate attractive cash returns.
Watch whether the Iridium acquisition closes on time and whether recurring service revenue continues growing.
Watch debt reduction after the transaction.
Most importantly, watch revenue, free cash flow, and backlog per share.
Because a company can become much larger without making each share proportionately more valuable.
What could change the thesis
The thesis would strengthen at the current valuation if Rocket Lab successfully launched Neutron, demonstrated repeatability, expanded Space Systems margins, and integrated Iridium without another large wave of dilution.
The valuation case would also improve if the share price fell far enough that the base case, rather than the aggressive case, could generate an attractive return.
The thesis would weaken if Neutron suffered another major delay, if cash consumption accelerated without matching contract growth, if backlog expanded while margins deteriorated, or if the share count continued growing faster than the company's eventual cash-generating capacity.
My conclusion
Rocket Lab may be one of the highest-quality publicly traded space companies.
That does not automatically make RKLB attractive at every price.
At approximately $70, investors are not purchasing an overlooked small-launch company.
They are purchasing a future vertically integrated space prime before its most important rocket has flown and before its largest acquisition has closed.
That future is possible.
It may even be probable.
But the current price leaves very little room for ordinary mistakes.
I would describe RKLB as a high-conviction business with a low-margin-of-safety valuation.
The company belongs on the watchlist.
The stock requires patience and position-size discipline.
The practical principle is simple:
Do not ask only whether Rocket Lab can reach orbit. It already has. Ask whether every new rocket, acquisition, and contract increases durable cash flow faster than Rocket Lab increases spending and financing claims.
Because in capital-intensive businesses, the company can win while the shareholder still overpays.
Financial figures and share price are as of September 23, 2026. Scenario values are analytical estimates for educational purposes, not financial advice.